SureTrader
Home > Boards > US Listed > Biotechs >

Threshold Pharmaceuticals Inc. (THLD)

THLD RSS Feed
Add THLD Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 2/5/2016 1:53:29 PM - Followers: 139 - Board type: Free - Posts Today: 0

Threshold Pharmaceuticals, Inc (THLD) 

 

 

http://www.thresholdpharm.com/

 

 



Company Address:
1300 Seaport Boulevard, Suite 500

Redwood City, CA 94063

605.474.8200

 

CIK:  0001183765


Threshold
is a biotechnology company focused on the discovery and development of therapeutics based on Tumor Hypoxia, a powerful scientific platform that offers broad potential to treat most solid tumors. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional drugs.

 

Management:  http://www.thresholdpharm.com/sec/management

 



http://www.thresholdpharm.com/sec/tumor_hypoxia

 

 


Clinical Pipeline:
 http://www.thresholdpharm.com/sec/clinical_pipeline

Product Pipeline: 
TH-302 is a hypoxia-activated prodrug (HAP) for the potential treatment of solid tumors. TH-302, which was discovered at Threshold, is a novel drug candidate that is activated under the metabolic conditions typical of cancer cells. We filed an IND (Investigational New Drug) with the FDA in April 2007 and started a Phase 1 clinical trial in July 2007. We initiated a second clinical trial of TH-302 in August 2008. This Phase 1/2 clinical trial is also focused on treating solid tumors.

Glufosfamide has been investigated for the potential treatment of pancreatic cancer, small cell lung cancer, platinum-resistant ovarian cancer and advanced soft tissue sarcoma. The soft tissue sarcoma trial provided evidence of clinical activity. Additionally, in a phase 2 clinical trial of glufosfamide in combination with gemcitabine for the treatment of advanced pancreatic cancer, the data indicated that glufosfamide plus gemcitabine may benefit patients with chemotherapy naive pancreatic cancer. The Company will be seeking a partner to continue development of glufosfamide in cancer.

2-Deoxyglucose, or 2DG, for the treatment of solid tumors, has been evaluated in a Phase 1 clinical trial alone and in combination with Taxotere.

 

Recent News: 

http://finance.yahoo.com/q/h?s=THLD+Headlines

 

 

Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001183765&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

 

 

Transfer Agent:
Mellon Investor Services LLC
85 Challenger Road
Ridgefield Park, NJ 07660
800.356.2017

BNYMellon Shareowner Services

 

Share Structure:

Outstanding Shares

33,702,242 as of Oct 31, 2010

 

Authorized Shares

150,000,000 as of Sep 30, 2010

 

Preferred Shares Authorized

2,000,000 as of Sep 30, 2010

 

No Preferreds Issued or Outstanding as of Sep 30, 2010

 

 

 

 

Investor Relations:
Denise T. Powell
Threshold Pharmaceuticals
650.474.8206

 

 

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
http://investorshub.advfn.com/boards/complex_terms.asp

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
THLD
Current Price
Volume:
Bid Ask Day's Range
Wiki
THLD News: Amended Statement of Ownership (sc 13g/a) 01/27/2016 03:58:49 PM
THLD News: Current Report Filing (8-k) 01/22/2016 05:12:46 PM
THLD News: Current Report Filing (8-k) 01/11/2016 06:14:03 AM
THLD News: Amended Statement of Ownership (sc 13g/a) 01/08/2016 02:04:32 PM
THLD News: Current Report Filing (8-k) 12/18/2015 04:24:45 PM
PostSubject
#2846   I like oversold stocks, this has a 70m rachelsdaddy 02/05/16 01:53:29 PM
#2845   Seems to be sidewinding right now. Need news. TKane 02/05/16 01:43:20 PM
#2844   Finviz has had this as oversold all week, rachelsdaddy 02/05/16 06:54:30 AM
#2843   I guess this POS THLD is at the R2DT 02/04/16 01:21:31 PM
#2842   We made the news :-D Threshold Pharmaceuticals Inc. (THLD) phinehas 02/04/16 11:37:33 AM
#2841   Not yet. Seems today's .27 moved the bottom. TKane 02/03/16 11:57:25 PM
#2840   Would like to hear some news about the R2DT 02/03/16 12:21:59 PM
#2839   A little luck in our pocket doesn't hurt R2DT 02/03/16 11:42:11 AM
#2838   Totally agree $1:-) phinehas 02/03/16 11:39:44 AM
#2837   It is always the buyers trying to get R2DT 02/03/16 11:37:52 AM
#2836   Difficult to know all the plans in the shadows. R2DT 02/03/16 11:29:07 AM
#2835   It looks like we need to wait until phinehas 02/03/16 10:53:22 AM
#2834   Have you seen this? phinehas 02/02/16 04:47:00 PM
#2833   :-D totally agree phinehas 02/02/16 04:33:12 PM
#2832   Need a new market maker on this pig. R2DT 02/02/16 04:04:21 PM
#2831   Anyone thinking that .29 was the bottom here? theStockGAMEoOo 02/02/16 02:48:14 AM
#2830   A flat day in search of news...but none. TKane 01/29/16 04:39:57 PM
#2829   New 13g/a. Blackrock reports its THLD holdings. Nice. TKane 01/28/16 07:49:38 AM
#2828   We are in a statistical outlier of a dog turd cannon 01/27/16 02:52:35 PM
#2827   I hope your assumption wasn't correct. This beebop_rocksteady 01/27/16 01:34:31 PM
#2826   Nice upper .30's today. Here's to .40's soon. TKane 01/26/16 05:30:03 PM
#2825   Looks like the next stop is up. beebop_rocksteady 01/26/16 01:29:27 PM
#2824   Well looks like the short selling is over phinehas 01/26/16 09:40:38 AM
#2823   That is a good question. Nothing other dog turd cannon 01/26/16 09:06:28 AM
#2822   Is it a confirmed separation or is it beebop_rocksteady 01/25/16 10:58:11 PM
#2821   Statistically stocks rebound to $1.00 after these announcements dog turd cannon 01/25/16 07:43:41 PM
#2820   What about a possible de-listing? Lonewolf1 01/25/16 06:20:57 PM
#2819   Agree, but it needs a little push phinehas 01/25/16 04:59:33 PM
#2818   This is headed back above a dollar. R2DT 01/25/16 03:51:52 PM
#2817   May the force be with THLD frankmertens 01/25/16 07:44:52 AM
#2816   Hope new news came out. Get a beebop_rocksteady 01/22/16 08:34:15 PM
#2815   Not a lot of money trading like it R2DT 01/22/16 03:14:13 PM
#2814   .37 now. Presentation session 2PM PST, 5PM EST TKane 01/22/16 02:53:55 PM
#2813   Peanut trading. Need that forward looking positive news release. R2DT 01/22/16 02:40:30 PM
#2812   Results of the MAESTRO trial will be presented TKane 01/22/16 02:08:54 PM
#2811   Apparently, there were some people or institutions with R2DT 01/22/16 09:46:43 AM
#2810   .40s would be a nice area to end R2DT 01/22/16 09:34:43 AM
#2809   Hope more investors jump in this and keep R2DT 01/22/16 09:32:06 AM
#2808   The market maker on this ticker is a R2DT 01/22/16 09:27:42 AM
#2807   Maybe we'll hear good news through the findings. The beebop_rocksteady 01/21/16 09:57:20 PM
#2806   Eod green! Needs more eyes. beebop_rocksteady 01/21/16 03:48:42 PM
#2805   Looks like THLD has stabilized and moving up. TKane 01/21/16 02:04:15 PM
#2804   Yes I agree 200% phinehas 01/21/16 12:35:42 PM
#2803   Such a low volume with this PPS improvement. R2DT 01/21/16 11:56:37 AM
#2802   It's coming I can feel it in my phinehas 01/21/16 11:52:57 AM
#2801   Sure would like to see this PPS continue R2DT 01/21/16 11:48:39 AM
#2800   Reverse splits are only bad in stocks with Dina 01/20/16 06:17:26 PM
#2799   THLD shares were definitely a gift this morning. TKane 01/20/16 05:51:23 PM
#2798   Agree, this might be the bounce we wanted phinehas 01/20/16 04:33:10 PM
#2797   Sure hope that good news is around the R2DT 01/20/16 03:13:39 PM
PostSubject